DIVIS LABORATORIES
Back to All Ratios
|
DIVIS LABORATORIES Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROCE(%) | 21.51 | 20.45 | 16.46 | 19.36 | 35.06 |
What is the latest Return on Capital Employed (ROCE) ratio of DIVIS LABORATORIES ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2026 | 21.51 |
| Mar2025 | 20.45 |
| Mar2024 | 16.46 |
| Mar2023 | 19.36 |
| Mar2022 | 35.06 |
How is Return on Capital Employed (ROCE) of DIVIS LABORATORIES Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2026 | 21.51 | 5.18 | |
| Mar2025 | 20.45 | 24.24 | |
| Mar2024 | 16.46 | -14.98 | |
| Mar2023 | 19.36 | -44.78 | |
| Mar2022 | 35.06 | - | |
Other Financial Ratios of DIVIS LABORATORIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹230,454.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
| MANKIND PHARMA | ₹97,756.1 Cr | -1% | -7.2% | -4.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.8% |
17% |
39.7% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses